Cheng Zou

651 total citations
32 papers, 510 citations indexed

About

Cheng Zou is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Cheng Zou has authored 32 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Cheng Zou's work include Effects and risks of endocrine disrupting chemicals (6 papers), Birth, Development, and Health (6 papers) and Per- and polyfluoroalkyl substances research (5 papers). Cheng Zou is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (6 papers), Birth, Development, and Health (6 papers) and Per- and polyfluoroalkyl substances research (5 papers). Cheng Zou collaborates with scholars based in China, United States and Chile. Cheng Zou's co-authors include John C. Osterman, Shiyong Wu, Dingxiao Zhang, Pei‐Ji Zhao, Yiyan Wang, Bin Xu, Ren‐Shan Ge, Jiangling Xiong, Kai Wang and Zhipeng Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Chemical Communications.

In The Last Decade

Cheng Zou

30 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng Zou China	13	254	58	54	51	50	32	510
Gregory F. Davis United States	9	336 1.3×	23 0.4×	53 1.0×	39 0.8×	26 0.5×	14	590
Yun Tian China	16	372 1.5×	46 0.8×	97 1.8×	116 2.3×	28 0.6×	27	688
Claudia A. McDonald United States	10	410 1.6×	74 1.3×	15 0.3×	27 0.5×	45 0.9×	11	600
Anjana Devi Tangutur India	10	381 1.5×	29 0.5×	63 1.2×	87 1.7×	18 0.4×	26	608
Jianjun Chen China	14	303 1.2×	17 0.3×	26 0.5×	54 1.1×	37 0.7×	42	641
Wei Fu China	14	408 1.6×	124 2.1×	135 2.5×	50 1.0×	47 0.9×	38	847
Ming‐Cheh Liu United States	15	286 1.1×	22 0.4×	30 0.6×	37 0.7×	42 0.8×	26	471
Antonia A. Nemec United States	14	415 1.6×	25 0.4×	116 2.1×	77 1.5×	109 2.2×	21	584

Countries citing papers authored by Cheng Zou

Since Specialization

Citations

This map shows the geographic impact of Cheng Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Zou more than expected).

Fields of papers citing papers by Cheng Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Zou. The network helps show where Cheng Zou may publish in the future.

Co-authorship network of co-authors of Cheng Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Zou. A scholar is included among the top collaborators of Cheng Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Zou. Cheng Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liao, Dandan, Yan Yang, Cheng Zou, et al.. (2025). Self-assembled GSH-responsive polycyclophosphazene loaded honokiol nano-drug for enhanced cancer therapy. Colloids and Surfaces B Biointerfaces. 255. 114876–114876.

Zou, Cheng, et al.. (2024). Comprehensive Characterization of the Integrin Family Across 32 Cancer Types. Genomics Proteomics & Bioinformatics. 22(4). 1 indexed citations

Li, Wenchao, Jiangling Xiong, Ruizhe Zhao, et al.. (2024). Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy. Cancer Letters. 602. 217214–217214. 6 indexed citations

Zou, Cheng, Wenchao Li, Ninghan Feng, et al.. (2024). Identification of an anaplastic subtype of prostate cancer amenable to therapies targeting SP1 or translation elongation. Science Advances. 10(14). eadm7098–eadm7098. 7 indexed citations

Zou, Cheng, et al.. (2024). An integrated ceRNA network identifies miR-375 as an upregulated miRNA playing a tumor suppressive role in aggressive prostate cancer. Oncogene. 43(21). 1594–1607. 3 indexed citations

Feng, Yuqing, Zenghui Li, Cheng Zou, et al.. (2024). Stabilization of RRBP1 mRNA via an m6A-dependent manner in prostate cancer constitutes a therapeutic vulnerability amenable to small-peptide inhibition of METTL3. Cellular and Molecular Life Sciences. 81(1). 414–414. 3 indexed citations

Li, Yang, Cheng Zou, Lili Tian, et al.. (2021). Bisphenol B stimulates Leydig cell proliferation but inhibits maturation in late pubertal rats. Food and Chemical Toxicology. 153. 112248–112248. 12 indexed citations

Li, Changchang, Cheng Zou, Xiu Xin, et al.. (2021). Perfluoroundecanoic acid inhibits Leydig cell development in pubertal male rats via inducing oxidative stress and autophagy. Toxicology and Applied Pharmacology. 415. 115440–115440. 18 indexed citations

Li, Changchang, Cheng Zou, Zengqiang Li, et al.. (2021). Perfluorotridecanoic acid inhibits fetal Leydig cell differentiation after in utero exposure in rats via increasing oxidative stress and autophagy. Environmental Toxicology. 36(6). 1206–1216. 7 indexed citations

10.

Zou, Cheng, Guoqing Ru, & Ming Zhao. (2021). A PHF1-TFE3 fusion atypical ossifying fibromyxoid tumor with prominent collagenous rosettes: Case report with a brief review. Experimental and Molecular Pathology. 123. 104686–104686. 4 indexed citations

11.

Li, Zengqiang, Changchang Li, Cheng Zou, et al.. (2020). Perfluoroheptanoic acid induces Leydig cell hyperplasia but inhibits spermatogenesis in rats after pubertal exposure. Toxicology. 448. 152633–152633. 23 indexed citations

12.

Pan, Peipei, Feifei Ma, Cheng Zou, et al.. (2020). Zearalenone disrupts the placental function of rats: A possible mechanism causing intrauterine growth restriction. Food and Chemical Toxicology. 145. 111698–111698. 21 indexed citations

13.

Pan, Peipei, Cheng Zou, Yiyan Wang, et al.. (2020). Tebuconazole exposure disrupts placental function and causes fetal low birth weight in rats. Chemosphere. 264(Pt 2). 128432–128432. 13 indexed citations

14.

Chen, Yanmei, et al.. (2015). Diterpenoids from the Endophytic Fungus Botryosphaeria sp. P483 of the Chinese Herbal Medicine Huperzia serrata. Molecules. 20(9). 16924–16932. 24 indexed citations

15.

Zou, Cheng, et al.. (1999). Structures of rubiarbonone B and C. Acta Botanica Yunnanica. 21(2). 256–259. 3 indexed citations

16.

Kumar, Sanjay, Janice R. Connor, Robert A. Dodds, et al.. (1999). Identification and Cloning of a Connective Tissue Growth Factor-like cDNA from Human Osteoblasts Encoding a Novel Regulator of Osteoblast Functions. Journal of Biological Chemistry. 274(24). 17123–17131. 88 indexed citations

17.

Zou, Cheng, et al.. (1998). Molecular cloning and characterization of a rabbit eIF2C protein. Gene. 211(2). 187–194. 61 indexed citations

18.

Chatterjee, Nabendu Sekhar, Cheng Zou, John C. Osterman, & Naba K. Gupta. (1997). Cloning and Characterization of the Promoter Region of a Gene Encoding a 67-kDa Glycoprotein. Journal of Biological Chemistry. 272(19). 12692–12698. 12 indexed citations

19.

Zou, Cheng. (1993). ANTITUMOR GLYCOCYCLOHEXAPEPTIDE FROM RUBIA YUNNANENSIS. Acta Botanica Yunnanica. 4 indexed citations

20.

Zou, Cheng, et al.. (1993). New arborane type triterpenoids from rubia yunnanensis (I). Acta Botanica Yunnanica. 15(1). 89–91. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact